Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Jobs report awaited for soaring US stocksDrivers warned: Visibility to be limited7 clubs earned over €100 million in a seasonColombians Choose Between Left and Right in ElectionTomorrow's weather favorable for weather-sensitive peopleRevolution Medicines Phase 3 Trial ResultsAzerbaijani jiu-jitsu fighter beats Armenian rivalProstate cancer death risk cut by 20% with J&J drugDefense Ministry releases weekly summaryEU May Raise Russian Oil Price CapJobs report awaited for soaring US stocksDrivers warned: Visibility to be limited7 clubs earned over €100 million in a seasonColombians Choose Between Left and Right in ElectionTomorrow's weather favorable for weather-sensitive peopleRevolution Medicines Phase 3 Trial ResultsAzerbaijani jiu-jitsu fighter beats Armenian rivalProstate cancer death risk cut by 20% with J&J drugDefense Ministry releases weekly summaryEU May Raise Russian Oil Price Cap
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#radiopharma

Latest news and interesting information about radiopharma.

Novartis radiopharma drug shows promise
Today / 12:04
|
457

Novartis radiopharma drug shows promise

Novartis experimental actinium-based radiopharma drug shows anti-tumor activity in prostate cancer, including in patients previously treated with Pluvicto.

STOCK MARKETS →
0
Telix completes enrollment in glioblastoma therapy trial
2026-05-18 21:11
|
691

Telix completes enrollment in glioblastoma therapy trial

Telix Pharmaceuticals completes patient enrollment for TLX101-Tx glioblastoma therapy trial.

COMPANY →
0
...